What are the diagnostic criteria for Clostridioides difficile infection?

Diagnostic Criteria for Clostridioides difficile Infection

The diagnosis of C. difficile infection requires both clinical criteria (≥3 unformed stools in 24 hours without alternative explanation) AND laboratory confirmation using either a NAAT alone or a multistep algorithm when institutional stool submission criteria are in place. 1

Clinical Criteria for Testing

Only test patients who meet ALL of the following:

• ≥3 unformed/loose stools in 24 hours (new onset and unexplained)
• No laxative use
• No other clear alternative cause for diarrhea
• Symptoms lasting ≥24 hours 1, 2

This clinical screening is critical because testing unselected patients leads to overdiagnosis by detecting asymptomatic carriers rather than true infection 3, 4.

Laboratory Diagnostic Approach

The optimal testing strategy depends on whether your institution has preagreed stool submission criteria:

WITH Institutional Stool Submission Criteria:

Use NAAT alone OR a multistep algorithm (GDH plus toxin; GDH plus toxin arbitrated by NAAT; or NAAT plus toxin) 1

WITHOUT Institutional Stool Submission Criteria:

Use a multistep algorithm with toxin testing (NOT NAAT alone) to improve positive predictive value and avoid overdiagnosis of colonization 1

Recommended multistep algorithms:

1. GDH screen → if positive → Toxin A/B EIA
2. GDH screen → if positive → Toxin A/B EIA → if discordant → NAAT arbitration
3. NAAT → if positive → Toxin A/B EIA confirmation 1, 4

Critical Testing Principles

Do NOT:

• Repeat testing within 7 days during the same diarrheal episode (strong recommendation) 1
• Test asymptomatic patients (except for epidemiological studies) 1
• Test formed stools
• Perform "test of cure" 1

Why the Two-Step Approach Matters

NAAT alone has ~95% sensitivity but detects both active infection AND asymptomatic colonization (10-30% of hospitalized patients) 3, 4. Studies show that patients positive by both NAAT and toxin testing have:

• Higher 30-day mortality (39% vs 3%) 1
• More complications (colectomy, ICU admission, readmission) 1
• Higher recurrence rates (31% vs 14%) 1

The presence of free toxin in stool correlates better with clinically significant disease and adverse outcomes 1, 4. Using NAAT alone without clinical criteria leads to overdiagnosis, unnecessary treatment, increased antimicrobial resistance, and higher healthcare costs 3.

Common Pitfalls to Avoid

• Testing patients on laxatives - creates false positives
• Testing without adequate diarrhea - most "positive" results will be colonization
• Using toxin EIA alone - sensitivity too low (53-60%), misses true cases 3
• Repeat testing after negative result - does not improve diagnostic yield meaningfully 1
• Testing children <12 months - high colonization rates make interpretation unreliable 5

Performance Characteristics

When disease prevalence is 5% (typical hospital setting):

• Toxin EIA: PPV 0.28-0.77, NPV 0.98-1.00 2
• NAAT: Sensitivity ~95%, but lower clinical specificity 3
• Two-step algorithms: Optimize both sensitivity and PPV 2, 4

The multistep approach increases positive predictive value compared to single-test strategies, which is essential given the relatively low prevalence of true CDI among tested patients 1, 2.